OpenAI developing new LLM codenamed ‘Garlic’ as ChatGPT goes into code red mode

OpenAI is reportedly developing a new LLM codenamed 'Garlic' (potentially to ship as GPT-5.2 or GPT-5.5 by early 2026) that internal evaluations claim outperforms Google’s Gemini 3 and Anthropic’s Claude Opus 4.5 in coding and reasoning, and signals a strategic push into specialized sectors such as biomedicine. CEO Sam Altman has issued a 'Code Red' memo reallocating resources to improve ChatGPT amid intensifying competition after Google’s Gemini 3 rollout and Anthropic’s recent release; independent data cited in the piece shows ChatGPT unique daily active users (7‑day average) fell ~6% in the two weeks after Gemini 3, while Google’s Gemini app reached ~650M MAUs in October (from 450M in July), raising questions about OpenAI’s user-growth-driven path to a stated $20B ARR and its $500B valuation.

Analysis

Market structure: Google (GOOGL/GOOG) and infrastructure providers (NVDA, AMZN, MSFT) are immediate beneficiaries — Google’s Gemini growth (650M MAU in Oct) shifts user attention and monetization power away from standalone ChatGPT (reported ~-6% DAU over two weeks). Specialized LLMs (biomed/healthcare) raise average contract sizes and margins vs. generalist consumer models, favoring large cloud incumbents that supply GPUs and enterprise sales teams. Smaller consumer/subscription-first AI apps are the most exposed to traffic and pricing pressure.

Risk assessment: Tail risks include regulatory action (EU/US safety/liability rules within 6–18 months), GPU supply shocks driving compute costs +20–50% real-term, or a catastrophic model failure that erodes trust. Immediate (days–weeks) risks: volatile DAU and PR cycles; short-term (months) risks: product rollouts, ad-revenue shifts; long-term (2026+) risks: specialization and verticalization changing TAMs. Hidden dependency: OpenAI’s monetization depends on Microsoft/Azure and developer ecosystem stickiness — loss of either magnifies downside.

Trade implications: Tilt portfolios toward GOOGL (ecosystem & ads), NVDA (compute scarcity), and cloud leaders; use option structures to buy asymmetric upside (12–18 month call spreads) while hedging regulatory tail risk with short-dated puts. Consider pair trades (long GOOGL, short ad-dependent social peers) to isolate model-ecosystem alpha; target horizon 3–12 months for rollout-driven moves, reassess on product releases or DAU inflection >±5% weekly.

Contrarian angles: Consensus treats OpenAI as doomed by Gemini but underestimates OpenAI’s R&D depth and potential enterprise pivot (Garlic → specialized biomed TAM). Market may be underpricing value capture in vertical AI (healthcare deals ≥5x consumer ARPU). Unintended consequence: fragmentation favors hyperscalers who can bundle model + compute + sales — increasing concentration risk but also creating concentrated long opportunities.

Key Decisions for Investors

• Establish a 2–3% long position in GOOGL (class A) with a 12-month price target +20% and a hard stop-loss at -12%; size to portfolio risk and re-evaluate after major product updates (next 3 months) or if Google MAU growth slows below +10% q/q.
• Add 1–2% overweight exposure to NVDA via 18-month LEAP calls (~20% OTM) to capture sustained AI compute demand; take profits at +40–60% and cap downside by buying a 6–9 month 10% OTM put equal to ~25% of option notional.
• Execute a relative-value pair: long GOOGL 2.0% vs short META 1.25% (or comparable ad-revenue dependent peer) over a 3–9 month horizon to exploit ecosystem integration; unwind if the pair diverges beyond 15% outperformance or if META reports ad momentum >10% q/q.
• Implement a low-cost asymmetric upside trade: buy a 12-month GOOGL call spread (long ~10% OTM / short ~25% OTM) sized 0.5–1% portfolio to lever upside from product rollouts, and simultaneously buy 6-month 10% OTM puts sized 0.3% as regulatory/tail protection; reprice if weekly ChatGPT DAU decline exceeds -5% or Gemini MAU rises >100M next quarter.